New insights into circulating FABP4: Interaction with cytokeratin 1 on endothelial cell membranes.
Fatty acid-binding protein 4 (FABP4) is an adipose tissue-secreted adipokine that is involved in the regulation of energetic metabolism and inflammation. Increased levels of circulating FABP4 have been detected in individuals with cardiovascular risk factors. Recent studies have demonstrated that FABP4 has a direct effect on peripheral tissues, specifically promoting vascular dysfunction; however, its mechanism of action is unknown. The objective of this work was to assess the specific interactions between exogenous FABP4 and the plasma membranes of endothelial cells. Immunofluorescence assays showed that exogenous FABP4 localized along the plasma membranes of human umbilical vein endothelial cells (HUVECs), interacting specifically with plasma membrane proteins. Anti-FABP4 immunoblotting revealed two covalent protein complexes containing FABP4 and its putative receptor; these complexes were approximately 108 kDa and 77 kDa in size. Proteomics and mass spectrometry experiments revealed that cytokeratin 1 (CK1) was the FABP4-binding protein. An anti-CK1 immunoblot confirmed the presence of CK1. FABP4-CK1 complexes were also detected in HAECs, HCASMCs, HepG2 cells and THP-1 cells. Pharmacological FABP4 inhibition by BMS309403 results in a slight decrease in the formation of these complexes, indicating that fatty acids may play a role in FABP4 functionality. In addition, we demonstrated that exogenous FABP4 crosses the plasma membrane to enter the cytoplasm and nucleus in HUVECs. These findings indicate that exogenous FABP4 interacts with plasma membrane proteins, specifically CK1. These data contribute to our current knowledge regarding the mechanism of action of circulating FABP4.
Research Unit on Lipids and Atherosclerosis, "Sant Joan" University Hospital, IISPV, CIBERDEM, Universitat Rovira i Virgili, Reus, Spain.
Paula
P
Saavedra
Research Unit on Lipids and Atherosclerosis, "Sant Joan" University Hospital, IISPV, CIBERDEM, Universitat Rovira i Virgili, Reus, Spain.
Josefa
J
Girona
Research Unit on Lipids and Atherosclerosis, "Sant Joan" University Hospital, IISPV, CIBERDEM, Universitat Rovira i Virgili, Reus, Spain.
Alba
A
Bosquet
Research Unit on Lipids and Atherosclerosis, "Sant Joan" University Hospital, IISPV, CIBERDEM, Universitat Rovira i Virgili, Reus, Spain.
Sandra
S
Guaita
Centre for Omics Science, Universitat Rovira i Virgili, Reus, Spain.
Núria
N
Canela
Research Unit on Lipids and Atherosclerosis, "Sant Joan" University Hospital, IISPV, CIBERDEM, Universitat Rovira i Virgili, Reus, Spain.
Gemma
G
Aragonès
Research Unit on Lipids and Atherosclerosis, "Sant Joan" University Hospital, IISPV, CIBERDEM, Universitat Rovira i Virgili, Reus, Spain.
Mercedes
M
Heras
Research Unit on Lipids and Atherosclerosis, "Sant Joan" University Hospital, IISPV, CIBERDEM, Universitat Rovira i Virgili, Reus, Spain. Electronic address: luis.masana@urv.cat.
Lluís
L
Masana
D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000235:genetics / Q000378:metabolism*; D002467:Cell Nucleus / Q000235:genetics / Q000378:metabolism; D050556:Fatty Acid-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D061307:Human Umbilical Vein Endothelial Cells / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D007633:Keratins / Q000235:genetics / Q000378:metabolism*; D046912:Multiprotein Complexes / Q000235:genetics / Q000378:metabolism*
C493410:FABP4 protein, human; D050556:Fatty Acid-Binding Proteins; D046912:Multiprotein Complexes; D007633:Keratins
Cell surface receptor; Cytokeratin 1; Endothelial cell; FABP4; FABP4 inhibition